https://www.yiliao.com/index.php?action=history&feed=atom&title=%E4%BD%95%E8%A3%95%E9%9A%86 2026-04-17T21:04:03Z 本wiki的该页面的版本历史 MediaWiki 1.35.1 https://www.yiliao.com/index.php?title=%E4%BD%95%E8%A3%95%E9%9A%86&diff=301614&oldid=prev 2016-03-22T03:18:42Z

<p>以“&#039;&#039;&#039;何裕隆&#039;&#039;&#039;，男，医学博士，<a href="/%E4%B8%BB%E4%BB%BB%E5%8C%BB%E5%B8%88" title="主任医师">主任医师</a>，教授，博士生导师。现就职于<a href="/%E4%B8%AD%E5%B1%B1%E5%A4%A7%E5%AD%A6%E9%99%84%E5%B1%9E%E7%AC%AC%E4%B8%80%E5%8C%BB%E9%99%A2" title="中山大学附属第一医院">中山大学附属第一医院</a>胃肠胰<a href="/%E5%A4%96%E7%A7%91" title="外科">外科</a>。Cancer Resea...”为内容创建页面</p> <p><b>新页面</b></p><div>'''何裕隆'''，男，医学博士，[[主任医师]]，教授，博士生导师。现就职于[[中山大学附属第一医院]]胃肠胰[[外科]]。Cancer Research, International Journal of Cancer, Cancer Letters, Annals Surgical Oncology等杂志发表论文350余篇。获中华医学会医学科技进步二等奖一项，三等奖一项，广东省科技进步一等奖一项，二等奖两项。<br /> == 基本资料 ==<br /> [[File:何裕隆.jpg|thumb|200px|right|何裕隆]] <br /> 姓名：何裕隆<br /> <br /> 性别：男<br /> <br /> 国籍：中国<br /> <br /> 职称：[[主任医师]]，教授，博士生导师<br /> <br /> 就职医院：[[中山大学附属第一医院]]<br /> <br /> 所在科室：胃肠胰外科<br /> <br /> 擅长疾病：擅长胃肠间质瘤(GIST)[[外科]]和综合治疗；擅长结直肠[[肿瘤]]、结[[直肠息肉]]及息肉病、炎症性肠病及肛门良性疾病的诊治，对于全直肠系膜切除、低位保功能的[[直肠癌]]手术、全结肠切除术、结肠“J” 型贮袋重建直肠术等。<br /> <br /> 出诊时间：星期二下午&lt;ref&gt;[http://www.gzsums.net/menzhen.aspx?tid=18 门诊安排]&lt;/ref&gt; （具体以医院当日排班为准）<br /> <br /> 门诊咨询电话：87330808<br /> <br /> 医院地址：广东省广州市中山二路58号<br /> <br /> == 简介 ==<br /> <br /> 何裕隆，男，医学博士，[[主任医师]]，教授，博士生导师。现就职于[[中山大学附属第一医院]]胃肠胰[[外科]]。Cancer Research, International Journal of Cancer, Cancer Letters, Annals Surgical Oncology等杂志发表论文350余篇。获中华医学会医学科技进步二等奖一项，三等奖一项，广东省科技进步一等奖一项，二等奖两项。<br /> <br /> == 社会兼职 ==<br /> <br /> 1.现任亚洲外科学会会员，中华医学会外科学分会委员，中华医学会外科学分会胃肠外科学组副组长，中国医师协会外科医师分会上消化道[[外科]]医师委员会副主任委员兼秘书长，中国抗癌协会胃癌专业委员会副主任委员，中国临床肿瘤学会（CSCO）胃肠间质瘤专家委员会副组长，中国医师协会第二届医学教育委员会委员。<br /> <br /> 2.广东省医学会胃肠外科学分会主任委员，广东省健康管理学会胃肠病学专业委员会主任委员，广东省医疗行业协会消化外科管理分会主任委员，广东省医学会第七届理事会理事，广东省抗癌协会第三届理事会常务理事，广东省抗癌协会胃癌专业委员会副主委，广东省抗癌协会胰腺癌专业委员会副主任，广东省抗癌协会大肠癌专业委员会常委，广东省医学会外科学分会第八届委员会常委，国家和广东省自然科学基金评委，中华医学科技奖评委，广东省科技奖评委。<br /> <br /> 3.《消化肿瘤杂志》(电子版)主编、《中华胃肠外科杂志》副主编、《中华普通外科文献》编辑部副主任、Annals of Surgery、Journal of Surgical Oncology、《中华外科杂志》、《中国实用外科杂志》、《中华普通外科杂志》等10余种杂志编委。<br /> <br /> == 研究方向 ==<br /> <br /> [[胃癌]][[外科]]治疗；[[胃癌]][[淋巴结]]转移机制和防治的研究；胃肠间质瘤（GIST）外科治和综合治疗及基础临床研究；遗传性胃肠道疾病的研究；结[[直肠癌]]的早期诊断和外科治疗；临床营养；[[胰腺]]疾病的诊治与基础研究；快速康复外科。<br /> <br /> == 擅长领域 ==<br /> <br /> 1.从事普通[[外科]]专业30余年，长期致力于[[胃癌]]外科研究，率先在国内开展和推广胃癌标准D2和D2(+)[[淋巴结]]清扫、鞘内[[淋巴结]]清扫，进展期[[胃癌]][[外科]]治疗后5年生存率超过60%，治疗效果达到国际先进水平。<br /> <br /> 2.擅长胃肠[[间质瘤]](GIST)外科和综合治疗；擅长结直肠[[肿瘤]]、结直肠息肉及息肉病、炎症性肠病及肛门良性疾病的诊治，对于全直肠系膜切除、低位保功能的[[直肠癌]]手术、全结肠切除术、结肠“J” 型贮袋重建直肠术等方面有深入研究和丰富经验。<br /> <br /> 3.对于[[胰腺]]疾病、腹膜后[[肿瘤]]、[[食道癌]]、食道良性疾病等有丰富的诊治经验，尤其在胃或结肠代食道术、保留[[幽门]]的Whipple术、消化道重建术等方面在国内属于领先水平。<br /> <br /> 4.熟练应用达芬奇机器人、[[腹腔镜]]及消化道内镜对胃肠道疾病进行诊断和治疗。<br /> <br /> == 教育及进修情况 ==<br /> <br /> 1984.7 毕业于中山医科大学留校工作<br /> <br /> 1996.6-1996.12 香港大学进修<br /> <br /> 2001.1-2002.12 美国Utah大学 博士后<br /> <br /> == 任职经历 ==<br /> <br /> 1997.12-2003.12 中山医科大学附属第一医院外科副教授、副主任医师<br /> <br /> 2003.12-至今 中山大学附属第一医院外科教授、主任医师<br /> <br /> 2003.5-2005.8 中山大学附属第一医院院长办公室副主任<br /> <br /> 2005.9-2014.4 中山大学附属第一医院胃肠胰专科主任<br /> <br /> 2005.9-至今 中山大学附属第一医院外科主任<br /> <br /> 2008.7-至今 中山大学胃癌诊治研究中心主任<br /> <br /> 2011.8-至今 中山大学附属第一医院院长助理<br /> <br /> 2014.4-至今 中山大学附属第一医院胃肠外科中心主任 <br /> <br /> == 科研 ==<br /> <br /> 1.[[胃癌]]淋巴管通透性与淋巴转移机制的研究 省自然科学基金 8万<br /> <br /> 2.[[大肠癌]]的早期诊断 省自然科学基金 5万<br /> <br /> 3.家族性息肉病[[遗传]]性研究 省科技厅基金 3万<br /> <br /> 4.胃肠[[肿瘤]][[遗传]]性研究 教育部回国人员启动基金 2万<br /> <br /> 5. 抗CEA单抗Fab`片段核素显像在胃肠[[肿瘤]]的应用 省卫生厅基金 2万<br /> <br /> == 论著 ==<br /> <br /> Cancer Research, International Journal of Cancer, Cancer Letters, Annals Surgical Oncology等杂志发表论文350余篇。<br /> <br /> == 获奖情况 ==<br /> 1.“提高[[胃癌]]外科疗效的临床与基础研究”分别获得2005年度中华医学会医学科技进步二等奖和广东省科技进步二等奖。<br /> <br /> 2.“[[直肠癌]]保功能手术”获得2006年度广东省科技进步一等奖。<br /> <br /> 3.“进展期[[胃癌]]外科治疗及应用基础研究”分获2010年度中华医学奖三等奖和广东省科技二等奖。<br /> <br /> == 专著 ==<br /> <br /> 1.主编《胃癌淋巴转移》人民卫生出版社 2011.4。<br /> <br /> 2.主编《直肠癌保肛手术》人民卫生出版社 2009.2。<br /> <br /> 3.副主编《普通外科疾病临床诊断与治疗方案》科学技术文献出版社 2012.5。<br /> <br /> 4.副主编《胃癌外科学》人民卫生出版社 2014.4。<br /> <br /> 5.主译《消化道肿瘤诊断与治疗》人民卫生出版社 2012.3。<br /> <br /> 6.参编《胃肠外科学》、《消化肿瘤外科学》、《胃肠外科手术学》、《外科学》本科教材、《外科临床手册》等著作。<br /> == 部分论文 ==<br /> <br /> 1. CXCL1 promotes tumor growth through VEGF pathway activation and is associated with inferior survival in gastric cancer. Cancer Letters 2015，359（2）：335-343<br /> <br /> 2. Low expression of SOCS-1 and SOCS-3 is a poor prognostic indicator for gastric cancer patients. Journal of Cancer Research and Clinical Oncology 2015,141（3）：443-452<br /> <br /> 3. Refractory left pleural effusion in an older patient: Atypical presentation of colorectal carcinoma. Oncology Letters 2015，9（3）：1055-1058<br /> <br /> 4. Uncontrolled inflammation induced by AEG-1 promotes gastric cancer and is associated with poor prognosis, Cancer Res 2014 Oct 1;74(19):5541-52.<br /> <br /> 5. Systematic review of nasogastric or nasojejunal decompression after gastrectomy for gastric cancer. European Journal of Surgical Oncology 2014，40（12）：1763-1770<br /> <br /> 6. The prognostic significance of the prognostic nutritional index in cancer: a systematic review and meta-analysis. Journal of Cancer Research and Clinical Oncology 2014，140（9）：1537-1549<br /> <br /> 7. RAD51 potentiates synergistic effects of chemotherapy with PCI-24781 and cis-diamminedichloroplatinum on gastric cancer. World Journal of Gastroenterology 2014，20（29）：10094-10107<br /> <br /> 8. Impact of Pre-existing Type-2 Diabetes on Patient Outcomes After Radical Resection for Gastric Cancer: A Retrospective Cohort Study. Dig Dis Sci 2014 May;59(5):1017-24.<br /> <br /> 9. Efficacy and complications of polyethylene glycols for treatment of constipation in children: a meta-analysis.，Medicine (Baltimore) 2014，93（16）：e65-e65<br /> <br /> 10.Clinicopathological features and trend changes of gastric carcinoma in Southern China. World J Gastroenterol. 2014 Apr 21;20(15)<br /> <br /> 11.Rare case of an abdominal mass: Reactive nodular fibrous pseudotumor of the stomach encroaching on multiple abdominal organs. World J Clin Cases. 2014 Apr 16;2(4):111-9.<br /> <br /> 12.Evaluation of para-aortic nodal dissection for locoregionally advanced gastric cancer with 1–3 involved para-aortic nodes. Chin Med J. 2014,127(3):435-441<br /> <br /> 13.Evaluation of Skeletonization of the Hepatoduodenal Ligament for the Lower Third Gastric Cancer by Propensity Score Analysis. Hepatogastroenterology. 2013 Oct;60(127):1789-96<br /> <br /> 14.Efficacy of adjuvant XELOX and FOLFOX6 chemotherapy after D2 dissection for gastric cancer. World J Gastroenterol. 2013 Jun 7;19(21):3309-15.<br /> <br /> 15.High-expression of DJ-1 and Loss of PTEN Associated with Tumor Metastasis and Correlated with Poor Prognosis of Gastric Carcinoma. Int J Med Sci. 2013 Sep 24;10(12):1689-97.<br /> <br /> 16.Combined evaluation of centromere protein H and Ki-67 as prognostic biomarker for patients with gastric carcinoma. Eur J Surg Oncol. 2013 Feb;39(2):141-9<br /> <br /> 17.Fast-Track Surgery Improves Postoperative Clinical Recovery and Immunity After Elective Surgery for Colorectal Carcinoma:Randomized Controlled Clinical Trial. World Journal of Surgery. 2012; 36(8):1874-1880.<br /> <br /> 18.Risk factors for adverse outcome in low rectal cancer. WJG.2012;1(1):64-69.<br /> <br /> 19.Fast track surgery accelerates the recovery of postoperative insulin sensitivity. Chinese Medical Journal. 2012;9,125(18):3261-3265.<br /> <br /> 20.Use of absorbable hemostatic gauze with medical adhesive is effective for achieving hemostasis in presacral hemorrhage. Am J Surg. 2012 Apr;203(4):5-8.<br /> <br /> 21.High CpG island methylator phenotype is associated with lymph node metastasis and prognosis in gastric cancer. Cancer Sci.2012 Jan; 103(1):73-79.<br /> <br /> 22.Lymphatic endothelial cell-secreted CXCL1 stimulates lymphangiogenesis and metastasis of gastriccancer. Int J Cancer.2012.Feb 15;130(4):787-797.<br /> <br /> 23.Tumor-associated macrophages promote angiogenesis and lymphangiogenesis of gastric cancer. J Surg Oncol.2012 Sep 15;106(4):462-468.<br /> <br /> 24.Successful treatment of gallbladder mixed adenoneuroendocrine carcinoma with neo-adjuvant chemotherapy. Diagnostic Pathology. 2012,7:163.<br /> <br /> 25.Abnormal expression of E-cadherin in tumor cells is associated with poor prognosis of gastric carcinoma. J Surg Oncol. 2012 Sep 1;106(3):304-10.<br /> <br /> 26.-)-Epigallocatechin-3-gallate inhibits VEGF expression induced by IL-6 via Stat3 in gastric cancer. World Journal of Gastroenterology.2011 May 14;17(18):2315-2325.<br /> <br /> 27. Astrocyte-elevated gene-1 overexpression is associated with poor prognosis in gastric cancer. Med Oncol. 2011; 28(2): 455-462.<br /> <br /> 28.High Expression of PRL-3 can Promote Growth of Gastric Cancer and Exhibits a Poor Prognostic Impact on Patients. Ann Surg Oncol. 2009,1,16(1):208-219.<br /> <br /> 29.Effect of diabetes mellitus on prognosis of the patients with colorectal cancer undergoing resection: a cohort study with 945 patients. Chinese Medical Journal.2010;123(21):3084-3088.<br /> <br /> 30.Clinicopathologic features and survival of patients with colorectal mucinous, signet-ring cell or non-mucinous adenocarcinoma: experience at an institution in southern China. Chinese Medical Journal. 2009,7,122(13):1486-1491.<br /> <br /> 31.Early operation for fulminant acute pancreatitis:a possible way to decrease mortality. Chinese Medical Journal. 2009,7,122(13):1492-1494.<br /> <br /> 32.Elevated PRL-3 expression was more frequently detected in the large primary gastric cancer and exhibits a poor prognostic impact on the patients. J Cancer Res Clin Oncol. 2009 Aug; 135(8):1041-1046.<br /> <br /> 33.Comparison of patients by family history with gastric and non-gastric cancer. World J Gastroenterol. 2009,15(21):2644-2650.<br /> <br /> 34.Expression and prognostic impact of PRL-3 in lymph node metastasis of gastric cancer: Its molecular mechanism was investigated using artificial microRNA interference. Int .J. ancer. 2008; 123,1439-1447 .<br /> <br /> 35.High Expression of PRL-3 can Promote Growth of Gastric Cancer and Exhibits a Poor Prognostic Impact on Patients. Ann Surg Oncol. 2009. 16(1): 208-19.<br /> <br /> 36.Spleen preservation in radical surgery for Gastric cardiac cancer. Ann Surg Oncolog, 2007; 14(4): 1312-1319<br /> 37.Is Albumin administration beneficial in early stage of postoperative hypoalbuminemia following gastrointestinal surgery?:A prospective randomized controlled trial. Am J Surg. 2008 Nov;196(5):751-5.<br /> <br /> 38.Effects of angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor blockers on lymphangiogenesis of gastric cancer in a nude mouse model. Chin Med J (Engl). 2008 Nov 5;121(21):2167-71<br /> <br /> == 相关链接 ==<br /> [http://www.gzsums.net/ 广州中山大学第一附属医院]<br /> [http://www.gzsums.net/zhuanjia_277.aspx 广州中山大学第一附属医院专家介绍：何裕隆]<br /> [http://www.gzsums.net/jiuyi.aspx 广州中山大学第一附属医院就医指引]<br /> == 参考资料 ==<br /> {{Reflist}}<br /> <br /> <br /> [[分类:广州中山大学第一附属医院]][[分类:行业人物]][[分类:胃肠外科]][[分类:主任医师]][[分类:人物]][[分类:医生]][[分类:科研人员]][[分类:博士生导师]]</div>

凌潇